NEU1 and sialidosis: To monitor the outcome, we assayed changes in Neu1 activity specifically in peripheral blood mononuclear cells (PBMCs) and measured total urinary sialic acids, because these standard assays in samples that can be obtained non-invasively mimic the way NEU1 activity would be monitored in sialidosis patients pre- and post-treatment.